Frontotemporal Dementia (FTD): Clinical Trials

19 trials for Frontotemporal Dementia (FTD), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 5 recruiting, 4 not yet recruiting, 3 enrolling by invitation. 5 Not applicable, 3 Phase 2, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 1, Enrolling by invitation 1, Not yet recruiting 1, Recruiting 1, Withdrawn 1
Phase 23Completed 2, Recruiting 1
Early Phase 11Recruiting 1

Follow Frontotemporal Dementia (FTD): new trials by email Literature Review of Frontotemporal Dementia (FTD) trials Research Report on Frontotemporal Dementia (FTD)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotemporal Dementia Spectrum
Frontotemporal Lobar Degeneration (FTLD), Frontotemporal Dementia (FTD)
Not yet recruitingBioSensics602026-11-012026-10-13
Speech-Based Artificial Intelligence for Detection of Dementia in Danish Patients (DetectAI)
Mini-mental State Examination, Addenbrooke's Cognitive Examination, Speech Task - Picture Description - Dementia (Diagnosis), Alzheimer Dementia (AD)
Not yet recruitingZealand University Hospital4402026-11-012026-09-02
Digital Measurements of Motor and Voice Functions in FTD
Frontotemporal Lobar Degeneration (FTLD), Frontotemporal Dementia (FTD)
Not yet recruitingBioSensics202026-08-012026-04-28
Retrospective Observational Study of Blood-based Biomarkers in the Diagnosis and Monitoring of Patients With a Neurodegenerative Disease or Mental Disorder
Alzheimer Disease, Dementia With Lewy Bodies (DLB)
Enrolling by invitationFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau17992026-02-192026-02-23
Transcranial Alternating Current Stimulation in Frontotemporal Dementia
Transcranial Alternating Current Stimulation, Sham Transcranial Alternating Current Stimulation - Transcranial Alternating Current Stimulation, Frontotemporal Dementia (FTD)
Not applicableRecruitingIRCCS Centro San Giovanni di Dio Fatebenefratelli302026-02-032026-09-24
Prospective Observational Study of the Relationship Between Sociodemographic Factors, Blood-based Biomarkers and Psychiatric Symptoms in Neurodegenerative Diseases and Mental Disorders
Major Depressive Disorder (MDD), Schizophenia Disorder
Enrolling by invitationFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau13102026-02-012026-04-24
Deep Cervical Lymphaticovenous Anastomosis Surgery for Moderate-to-Advanced Dementia Patients
Deep Cervical Lymphaticovenous Anastomosis(DLVA) - Alzheimer Disease, Lewy Body Dementia (LBD)
Not applicableNot yet recruitingRenJi Hospital852025-05-282025-05-28
Vortioxetine for the Treatment of Mood and Cognitive Symptoms in Frontotemporal Dementia
Vortioxetine - Fronto-temporal Dementia, Fronto-temporal Lobar Dementia
Phase 2RecruitingJohns Hopkins University502025-03-202026-03-09
Disease Biosignatures in ALS/FTD Spectrum: New Impactful Biological Perspectives Beyond Clinical Approaches
ALS (Amyotrophic Lateral Sclerosis), FTD
Active not recruitingFondazione I.R.C.C.S. Istituto Neurologico Carlo Besta2302025-02-272026-08-28
Discovery and Validation of Protein Structural Complexes in Circulating Biofluids As Novel Biomarkers for Early Diagnosis, Prognosis and Therapeutic Management of Patients Affected by Neurodegenerative Disorders
Genetic: whole genome sequencing, whole exome sequencing - Parkinson Disease, Amyotrophic Lateral Sclerosis (ALS)
RecruitingNeuromed IRCCS1102025-02-042025-03-18
[18F]ACI-19626 PET in TDP-43 Proteinopathies
[18F]ACI-19626 - Frontotemporal Dementia (FTD), Amyotrophic Lateral Sclerosis (ALS)
Early Phase 1RecruitingAC Immune SA452025-01-212026-08-26
Predict to Prevent PGRN Disease
Clinical, behavioral and cognitive evaluation, blood sampling, brain MRI - Frontotemporal Dementia (FTD), GRN Related Frontotemporal Dementia
Not applicableWithdrawnAssistance Publique - Hôpitaux de Paris2025-01-012025-03-21
The Role of Advanced Electroencephalographic Data as Marker of Pathology and Prognosis in Primary Dementias
Electroencephalogram, 3 Tesla MRI, Apolipoprotein E genetic test - Alzheimer Disease, Lewy Body Dementia (LBD)
Not applicableEnrolling by invitationIRCCS San Raffaele1752021-11-052025-02-17
A Biomarker-chip Assay in Preserved Red Blood Cells for the Diagnosis of Alzheimer's Disease
Alzheimer's Disease (AD), Neurodegenerative Disease
CompletedAmoneta Diagnostics SAS1502017-03-232025-12-29
Low-Dose Lithium for the Treatment of Behavioral Symptoms in Frontotemporal Dementia
Lithium Carbonate, Placebo - Frontotemporal Dementia (FTD)
Phase 2CompletedColumbia University172017-01-272025-02-03
A Medium Chain Triglyceride Intervention for Patients With Alzheimer Disease
Ketogenic medium chain triglyceride drink (MCT drink), Placebo - Alzheimer's Disease, Primary Progressive Non-fluent Aphasia
Not applicableCompletedUniversity of British Columbia432016-09-012026-04-23
Comprehensive Assessment of Neurodegeneration and Dementia
Dementia, Mild Cognitive Impairment (MCI)
RecruitingMcGill University15732016-06-012026-01-20
Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT Mutations
18F-AV-1451 - Frontotemporal Lobar Degeneration (FTLD), Frontotemporal Dementia (FTD)
Phase 2CompletedColumbia University72016-04-012019-12-06
Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)
FTLD, Progressive Supranuclear Palsy (PSP)
CompletedUniversity of California, San Francisco14892014-09-012021-05-21

Narrower conditions

Frontotemporal Dementia (19)  ·  Alzheimer Disease (9)  ·  Lewy Body Disease (6)  ·  Amyotrophic Lateral Sclerosis (5)  ·  Dementia (5)  ·  Frontotemporal Lobar Degeneration (5)  ·  Parkinson Disease (5)  ·  Cognitive Dysfunction (3)  ·  Corticobasal Degeneration (3)  ·  Depressive Disorder, Major (2)  ·  Primary Progressive Nonfluent Aphasia (2)  ·  Aphasia, Primary Progressive (1)  ·  Charcot-Marie-Tooth disease, Type 1F (1)  ·  Color Vision Defects (1)  ·  Dementia, Vascular (1)

Broader conditions

Brain Diseases (19)  ·  Central Nervous System Diseases (19)  ·  Metabolic Diseases (19)  ·  Nervous System Diseases (19)  ·  Neurocognitive Disorders (19)  ·  Nutritional and Metabolic Diseases (19)  ·  Proteostasis Deficiencies (19)  ·  Mental Disorders (18)  ·  Neurodegenerative Diseases (18)  ·  TDP-43 Proteinopathies (18)  ·  Dementia (14)  ·  Frontotemporal Lobar Degeneration (14)  ·  Tauopathies (12)  ·  Basal Ganglia Diseases (8)  ·  Movement Disorders (8)

Interventions

Blood Specimen Collection (2)  ·  7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole (1)  ·  Diploidy (1)  ·  Electroencephalography (1)  ·  Exome Sequencing (1)  ·  Lithium Carbonate (1)  ·  Spinal Puncture (1)  ·  Transcranial Direct Current Stimulation (1)  ·  Vortioxetine (1)

Sponsors

BioSensics (2)  ·  Columbia University (2)  ·  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (2)  ·  AC Immune SA (1)  ·  Amoneta Diagnostics SAS (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta (1)  ·  IRCCS Centro San Giovanni di Dio Fatebenefratelli (1)  ·  IRCCS San Raffaele (1)  ·  Johns Hopkins University (1)  ·  McGill University (1)  ·  Neuromed IRCCS (1)  ·  RenJi Hospital (1)  ·  University of British Columbia (1)  ·  University of California, San Francisco (1)

Countries

United States (5)  ·  Italy (4)  ·  Canada (3)  ·  Spain (2)  ·  China (1)  ·  Denmark (1)  ·  Netherlands (1)  ·  Switzerland (1)

Top investigators

Edward Huey, MD (2)  ·  Adam L Boxer, MD, PhD (1)  ·  Christopher Morrow, MD (1)  ·  Elsmarieke van de Giessen, MD (1)  ·  Haakon Nygaard, MD, PhD (1)  ·  Howard Feldman, MD (1)  ·  Jaspreet Bhangu, MB (1)  ·  Massimo MF Filippi, MD (1)  ·  Michael Borrie, MD (1)  ·  Natalie Philips, PhD (1)

Results publications

PMID 11976975, PMID 12092785, PMID 12566600, PMID 15753425, PMID 20633386, PMID 21325651, PMID 21396882, PMID 21810890, PMID 22689311, PMID 23963806, PMID 28709880, PMID 31925823, PMID 32987305, PMID 33017671, PMID 33827960, PMID 35492244, PMID 35607946, PMID 35790423, PMID 39136447

NIH funding

2017 (1), K23AG088248 (1), R01NS076837 (1), U54NS092089 (1)